Related Experiment Videos
Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma.
1Division of Pharmacological Sciences and Toxicology, United Medical School, London.
The British Journal of Ophthalmology
|February 1, 1991
Summary
Pulsatile ocular blood flow is significantly reduced in chronic open-angle glaucoma patients. Topical timolol treatment did not improve ocular blood flow or postural responses in these patients.
Area of Science:
- Ophthalmology
- Ocular Physiology
- Glaucoma Research
Background:
- Chronic open-angle glaucoma (COAG) is a leading cause of irreversible blindness.
- Understanding ocular hemodynamics is crucial for glaucoma management.
- Pulsatile ocular blood flow (POBF) reflects the dynamic blood supply to the eye.
Purpose of the Study:
- To investigate pulsatile ocular blood flow (POBF) in patients with chronic open-angle glaucoma (COAG).
- To assess the effect of timolol eyedrops on POBF and intraocular pressure (IOP) in COAG patients.
- To evaluate the impact of postural changes (erect vs. supine) on POBF and IOP in this cohort.
Main Methods:
- POBF and intraocular pressure (IOP) were measured in 15 COAG patients.
- Measurements were taken during three phases: regular timolol treatment, two weeks after withdrawal, and two weeks after reinstitution.
- Data were collected in both erect and supine positions using pneumotonometry and a Langham ocular blood flow system.
Main Results:
- Assumption of the supine posture significantly increased IOP and decreased POBF in all study phases.
- Timolol treatment lowered mean IOP but did not affect postural IOP changes or POBF.
- COAG patients exhibited significantly lower POBF and ocular pulse amplitude compared to ocular hypertension subjects, independent of IOP levels.
Conclusions:
- Pulsatile ocular blood flow is significantly diminished in patients with chronic open-angle glaucoma.
- Topical timolol therapy does not enhance POBF or alter the postural response in COAG patients.
- These findings suggest impaired ocular blood flow regulation in glaucoma that is not responsive to standard timolol treatment.